Jian Meng

Fujian Provincial Key Laboratory Of Neurodegenerative Disease And Aging Research
Xiamen, 361102, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

FMRP attenuates Tau pathology through the CDK5/p35 signaling pathway.

FMRP attenuates Tau pathology through the CDK5/p35 signaling pathway.

Journal: Neurobiology of disease

Published: August 13, 2025

Astrocytic PYGM attenuates tau pathology by promoting lactate-mediated neuroprotection.

Astrocytic PYGM attenuates tau pathology by promoting lactate-mediated neuroprotection.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: July 11, 2025

CSRP2 promotes the glioblastoma mesenchymal phenotype via p130Cas-mediated NF-κB and MAPK pathways.

CSRP2 promotes the glioblastoma mesenchymal phenotype via p130Cas-mediated NF-κB and MAPK pathways.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 13, 2025

TMEM59 deficiency activates chaperone-mediated autophagy and ameliorates disease-like pathologies in tauopathy model mice.

TMEM59 deficiency activates chaperone-mediated autophagy and ameliorates disease-like pathologies in tauopathy model mice.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 03, 2025

Sorafenib promotes the E3 ubiquitin ligase FBXW7 to increase tau degradation and ameliorate tauopathies.

Sorafenib promotes the E3 ubiquitin ligase FBXW7 to increase tau degradation and ameliorate tauopathies.

Journal: Acta pharmaceutica Sinica. B

Published: January 21, 2025

Microglial CD2AP deficiency exerts protection in an Alzheimer's disease model of amyloidosis.

Microglial CD2AP deficiency exerts protection in an Alzheimer's disease model of amyloidosis.

Journal: Molecular neurodegeneration

Published: August 29, 2024

RPS23RG1 inhibits SORT1-mediated lysosomal degradation of MDGA2 to protect against autism.

RPS23RG1 inhibits SORT1-mediated lysosomal degradation of MDGA2 to protect against autism.

Journal: Theranostics

Published: July 03, 2024

Electrophysiology-based screening identifies neuronal HtrA serine peptidase 2 (HTRA2) as a synaptic plasticity regulator participating in tauopathy.

Electrophysiology-based screening identifies neuronal HtrA serine peptidase 2 (HTRA2) as a synaptic plasticity regulator participating in tauopathy.

Journal: Translational psychiatry

Published: May 30, 2024

Microglial Dysfunction in Autism Spectrum Disorder.

Microglial Dysfunction in Autism Spectrum Disorder.

Journal: The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry

Published: May 07, 2024

TREM2 regulates microglial phagocytosis of synapses in innate immune tolerance.

TREM2 regulates microglial phagocytosis of synapses in innate immune tolerance.

Journal: International immunopharmacology

Published: November 08, 2023

Long-term potentiation-based screening identifies neuronal PYGM as a synaptic plasticity regulator participating in Alzheimer's disease.

Long-term potentiation-based screening identifies neuronal PYGM as a synaptic plasticity regulator participating in Alzheimer's disease.

Journal: Zoological research

Published: August 03, 2023

Tau reduction attenuates autism-like features in Fmr1 knockout mice.

Tau reduction attenuates autism-like features in Fmr1 knockout mice.

Journal: Molecular autism

Published: July 19, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026